Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Maximilian, Fleischmann"'
Autor:
Zahra Khodabakhshi, Laura Motisi, Andrea Bink, Martina A. Broglie, Niels J. Rupp, Maximilian Fleischmann, Jens von der Grün, Matthias Guckenberger, Stephanie Tanadini-Lang, Panagiotis Balermpas
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Defining the exact histological features of salivary gland malignancies before treatment remains an unsolved problem that compromises the ability to tailor further therapeutic steps individually. Radiomics, a new methodology to extract quant
Externí odkaz:
https://doaj.org/article/50509ccbea254b86b6892c48bca898ca
Autor:
Ria Winkelmann, Maja Weißgerber, Peter J. Wild, Julia Bein, Maximilian Fleischmann, Melanie Demes, Panagiotis Balermpas, Andreas Loth, Katrin Bankov, Jens von der Grün
Publikováno v:
Life, Vol 14, Iss 9, p 1089 (2024)
Salivary gland cancer (SGC) is a rare cancer that can present a diagnostic challenge to pathologists, with emerging, but still limited options for the treatment of recurrent/metastatic disease. We aimed to characterize the cohort of salivary gland ca
Externí odkaz:
https://doaj.org/article/0e1c9b239de44339848e511c52c52aba
Autor:
Markus Hecht, Benjamin Frey, Udo S. Gaipl, Xie Tianyu, Markus Eckstein, Anna-Jasmina Donaubauer, Gunther Klautke, Thomas Illmer, Maximilian Fleischmann, Simon Laban, Matthias G. Hautmann, Bálint Tamaskovics, Thomas B. Brunner, Ina Becker, Jian-Guo Zhou, Arndt Hartmann, Rainer Fietkau, Heinrich Iro, Michael Döllinger, Antoniu-Oreste Gostian, Andreas M. Kist
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 49, Iss , Pp 100953- (2024)
Purpose: Individual prediction of treatment response is crucial for personalized treatment in multimodal approaches against head-and-neck squamous cell carcinoma (HNSCC). So far, no reliable predictive parameters for treatment schemes containing immu
Externí odkaz:
https://doaj.org/article/545805f66b504b9d8a9522c916fbe3dc
Autor:
Denys Oliinyk, Maximilian Fleischmann, Dilfuza Ernafasova, Caroline Tschernjawski, Sebastian Scholl, Andreas Hochhaus, Florian Meier-Rosar
Publikováno v:
HemaSphere, Vol 7, p e8359427 (2023)
Externí odkaz:
https://doaj.org/article/c981470b46834db7af44b384adfa6ae2
Autor:
Maximilian Fleischmann, Nathalie Urban, Ole Hansen, Ulf Schnetzke, Florian Heidel, Andreas Hochhaus, Joerg Mueller, Sebastian Scholl
Publikováno v:
HemaSphere, Vol 7, p e0157326 (2023)
Externí odkaz:
https://doaj.org/article/33ce66d5770e4d4d917f966ffccfc345
Autor:
Maximilian Fleischmann, Markus Diefenhardt, Adele M. Nicolas, Franz Rödel, Michael Ghadimi, Ralf-Dieter Hofheinz, Florian R. Greten, Claus Rödel, Emmanouil Fokas
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 34, Iss , Pp 99-106 (2022)
Purpose: Recent advances in the treatment algorithm of locally advanced rectal cancer (LARC) have significantly improved complete response (CR) rates and disease-free survival (DFS), but therapy resistance, with its substantial impact on outcomes and
Externí odkaz:
https://doaj.org/article/a3a67b449ea5465b978c7ac451018339
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 4, Pp 458-467 (2021)
In combination with radiotherapy, immunotherapy is becoming an increasingly used strategy in treating advanced, recurrent, or metastatic cancer. The evident impact of radiotherapy on local and systemic immune response is an indication of the synergis
Externí odkaz:
https://doaj.org/article/2bfa36da9e1b4b33b2c1b679c1c66145
Autor:
Georgios Chatzikonstantinou, Markus Diefenhardt, Maximilian Fleischmann, Markus Meissner, Christian Scherf, Martin Trommel, Ulla Ramm, Claus Rödel, Nikolaos Tselis, Jörg Licher
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 21:35-41
Autor:
Georgios Chatzikonstantinou, Markus Diefenhardt, Maximilian Fleischmann, Markus Meissner, Christian Scherf, Martin Trommel, Ulla Ramm, Claus Rödel, Nikolaos Tselis, Jörg Licher
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 21:35-43
Autor:
Alina Frey, Daniel Martin, Louisa D’Cruz, Emmanouil Fokas, Claus Rödel, Maximilian Fleischmann
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 598 (2022)
Despite the implementation of consolidative immune checkpoint inhibition after definitive chemoradiotherapy (CRT), the prognosis for locally advanced non-small-cell lung cancer (NSCLC) remains poor. We assessed the impact of the C-reactive protein (C
Externí odkaz:
https://doaj.org/article/80457ad3ab754411beb43d1af5ce58af